547A Stock Overview
A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ambu A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | DKK 15.69 |
| 52 Week High | DKK 20.61 |
| 52 Week Low | DKK 11.83 |
| Beta | 0.79 |
| 11 Month Change | -7.71% |
| 3 Month Change | -23.11% |
| 1 Year Change | 30.11% |
| 33 Year Change | -40.45% |
| 5 Year Change | 1.06% |
| Change since IPO | -47.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| 547A | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -4.4% | -3.7% | -0.5% |
| 1Y | 30.1% | -4.2% | 8.3% |
Return vs Industry: 547A exceeded the German Medical Equipment industry which returned -4.2% over the past year.
Return vs Market: 547A exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| 547A volatility | |
|---|---|
| 547A Average Weekly Movement | 5.3% |
| Medical Equipment Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 547A has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 547A's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 5,196 | Britt Jensen | www.ambu.com |
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.
Ambu A/S Fundamentals Summary
| 547A fundamental statistics | |
|---|---|
| Market cap | €4.09b |
| Earnings (TTM) | €31.50m |
| Revenue (TTM) | €722.71m |
129.8x
P/E Ratio5.7x
P/S RatioIs 547A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 547A income statement (TTM) | |
|---|---|
| Revenue | DKK 5.39b |
| Cost of Revenue | DKK 2.19b |
| Gross Profit | DKK 3.20b |
| Other Expenses | DKK 2.97b |
| Earnings | DKK 235.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Jan 30, 2025
| Earnings per share (EPS) | 0.88 |
| Gross Margin | 59.38% |
| Net Profit Margin | 4.36% |
| Debt/Equity Ratio | 0% |
How did 547A perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield43%
Payout RatioDoes 547A pay a reliable dividends?
See 547A dividend history and benchmarks| Ambu dividend dates | |
|---|---|
| Ex Dividend Date | Dec 05 2024 |
| Dividend Pay Date | Dec 09 2024 |
| Days until Ex dividend | 16 days |
| Days until Dividend pay date | 20 days |
Does 547A pay a reliable dividends?
See 547A dividend history and benchmarks